SB0017 PH 1.21.2025 HHS — Senate Hearing Report

New Bill Status Search

Senate Health and Human Services Committee

Sophie Walsh  271-3469

 

SB 17-FN, relative to insurance cost-sharing calculations.

 

Hearing Date: January 15, 2025

 

Time Opened: 9:38 a.m. Time Closed: 10:58 a.m.

 

Members of the Committee Present:  Senators Rochefort, Avard, Birdsell, Prentiss and Long

 

Members of the Committee Absent  : None

 

Bill Analysis: This bill provides that, when calculating an enrollee's contribution to cost-sharing requirements, the insurer or pharmacy benefits manager shall include any amount paid by the enrollee or paid on their behalf.  The bill includes a limited exception for health savings account-qualified high deductible health plans if application of the requirement would result in account ineligibility under the Internal Revenue Code.

 

Sponsors:  

Sen. Innis

 

 

________________________________________________________________________________

 

Who supports the bill:  Sen. Innis, Mike Rollo (American Cancer Society Cancer Action Network), Susanna von Oettingen, Amanda Attiya (Cystic Fibrosis Foundation), and Kathryn Morgan.

Who opposes the bill:  Paula Rogers (AHIP), Lindsay Nadeau (Cigna), Cam Lapine (Cigna), Curtis J. Barry (Pharmaceutical Care Management Association), Sam Hallemeier (Pharmaceutical Care Management Association), Sabrina Dunlap (Anthem), and Peter Bragdon (Harvard-Pilgrim).

Who is neutral on the bill: No one.

 

Summary of testimony presented:

 

Senator Dan Innis, Senate District 7

 

Susanna von Oettingen

 

Paula Rogers, America’s Health Insurance Plans (AHIP)

 

Curtis J. Barry and Sam Hallemeier, Pharmaceutical Care Management Association (PCMA)

 

Peter Bragdon, Harvard-Pilgrim

 

Sabrina Dunlap, Anthem

 

Mike Rollo, American Cancer Society Cancer Action Network (ACSCAN)

 

Peter Bragdon, Harvard-Pilgrim

 

 

 

 

 

 

 

 

 

 

 

 

 

SW

Date Hearing Report completed:  January 21, 2025